Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease-Reference-Cited by-同舟云学术

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

Published:2009 Issue:20 Volume:15 Page:2506
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Donadon Valter,Balbi Massimiliano,Ghersetti Michela,Grazioli Silvia,Perciaccante Antonio,Valentina Giovanni Della,Gardenal Rita,Mas Maria Dal,Casarin Pietro,Zanette Giorgio,Miranda Cesare

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference31 articles.

1. World Health Organization. Mortality database //www.who.int/whosis/whostat/EN_WHS08_Part1.pdf. Accessed 4 December: Available from: URL: http; 2008;.

2. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777-782.

3. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-539.

4. Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006;29:2701-2707.

5. Sloan FA, Bethel MA, Ruiz D Jr, Shea AM, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 2008;168:192-199; discussion 199.

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis;Hepatology Communications;2023-12

2. Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions;Cancers;2023-09-13

3. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma;Hepatology Research;2023-05-30

4. Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions;Journal of Gastrointestinal Oncology;2022-10

5. Recent Insights of Metformin on Hepatocellular Carcinoma (HCC);Mini-Reviews in Medicinal Chemistry;2022-06-23